Novosti
|
This journal is indexed in Scopus |
|---|
Year 2012 Vol. 20 No 4
LECTURES, REVIEWS
A.A. BAESHKO, S.N. TIKHON, E.V. KRYZHOVA, P.V. MARKAUTSAN, V.F. VARTANYAN, V.M. DECHKO, K.M. KOVALEVICH, N.G. SHESTAK
FOAM-FORM SCLEROTHERAPY: HISTORY OF THE DEVELOPMENT AND PRESENT-DAY FINDINGS
EE “Belarusian State Medical University”, Minsk
The Republic of Belarus
Sclerotherapy is a modern, safe and effective method of the chronic venous diseases treatment, which has gained a great popularity among phlebologists of all countries. During the past decade the qualitatively new technology, a foam scleraobliteration of veins, based on the injection of the preparation in the form of small dispersed foam has been introduced into the clinical practice. Ultrasound control of the procedure not only simplifies the stage of the dilated veins puncture, but also gives an opportunity to estimate immediate and long-term results of the treatment. The principles of the foam-form sclerotherapy, the history of its development, efficacy and possible side-effects are viewed in this article on the literature basis using electronic resources of PubMed, MEDLINE, EMBASE.
1. Orbach EJ: Sclerotherapy of varicose veins: utilization of intravenous airblock. Am J Surg. 1944; 66:362–66.
2. Harkins H, Horman PH. Embolism by Air and Oxygen: Comparative Studies. Proceedings of the Society for Experimental Biology and Medicine. 1934;32:178–81.
3. Orbach EJ. The Thrombogenic Property of Foam of a Synthetic Anionic Detergent (Sodium Tetradecyl Sulfate N.N.R.). Angiolology. 1950;1:237–43.
4. Woolman J. History of sclerosants foams: persons, techniques, patents and medical improvements. In: Bergan J, Van Le Chang, eds. Foam sclerotherapy: A Textbook. London, UK: Royal Society of Medicine Press; 2008.
5. Cabrera JR. Extending the Limits of Sclerotherapy: New Sclerosing Products. Phlebologie. 1997;50(2):181–88.
6. Monfreux A. Sclerosant Treatment of Saphenous Truncs and Their Large Calibre Collaterals by the MUS Method. Phlebologie. 1997;50(3):351–53.
7. Henriet JP. Un an de pratiquequotidienne de la scle?rothe?rapie (veinesreticulaires et te?leangiectasies) par mousse de polidocanol: faisebilite?, re?sultats, complications. Phle?bologie. 1997;50:355–60.
8. Frullini A. New Technique in Producing Sclerosing Foam in a Disposable Syringe. Dermatol Surg. 2000;26:705–706.
9. Sadoun S, Henriet JP, ed. "Sclerosing Foam: Material and Methods," in Foam Sclerotherapy State of the Art. Editions Phlebologiques Francaises, 2002. p. 25–32.
10. Tessari L. Nouvelle technique d’obtention de la scleromousse. Phlebology. 2000;53:129–33.
11. Breu FX. Guggenbichler S, Wollmann JC. 2nd European Consensus Meeting on Foam Sclerotherapy, Tegernsee, Germany, 2006 yar. Vasa. 2008;37(1 Suppl):71.
12. Rabe E, Pannier F, Gerlach H, Breu FX, Guggenbichler S, Wollmann JC. Sclerotherapy is considered to be the method of choice.Clerotherapy of varicose veins - Guidelines. (ICD 10: I83.0, I83.1, I83.2, I83.9). In: Bergan JJ, Le Cheng V (Ed): Foam. Sclerotherapy: A Textbook. Royal Society of Medicine Press 2008.
13. Rabe E. Pannier-Fischer F, Geriach H, Breu FX, Guggenbichler S, Zabel M; German Society of Phlebology. Guidelines for sclerotherapy of varicose veins (ICD 10: I83.0, 183.1, I83.2, and I83.90. J Dermatol Surg. 2004 May;30(5):687–93; discussion 693.
14. Rao J. Goldman MP. Stabiility of foam in sclerotherapy: Differences between Sodium Tetradecyl Sulfate and Polidocanol. Dermatol Surg. 2005;31(1):19–22.
15. Breux FX, Marshall M. Sclerotherapiemitpolidokcanol in einerangiologisch-phlebologischenSpezialpraxis. Prospektive und retrospective ErhebunguberErgebnisse und Komplikationen. Plebologie. 2003;32:76–80.
16. Goldman MP, Kaplan RP, Oki LN, Cavender PA, Strick RA, Bennett RG. Sclerosing agents in the treatment of telangiectasia. Comparison of the clinical and histologic effects of intravascular polidocanol, sodium tetradecyl sulfate, and hypertonic saline in the dorsal rabbit ear vein model. Arch Dermatol. 1987;123:1196–201.
17. Cabrera J, Garcia-Olmedo MA. Sclerosants in microfoam: a new approach in angiology. Angioljgy. 2001;20:322–29.
18.Goldman MP. Treatment of varicose and telangiectatic leg veins: double blind prospective comparative trial between aethoxyskerol and sotradecol. Dermatol Surg. 2002;28:52–55.
19. Bush RG, Derrick M, Manjonev D. Major neurological events following foam sclerotherapy. Phlebology. 2008;23:189–92.
20. Gillet JL, Guedes JM, Guex JJ, Hamel-Desnos C, Schadeck M, Lauseker M, Allaert FA. Side-effects and complications of foam sclerotherapy of the great and small saphenous veins: a controlled multicentre prospective study including 1,025 patients. Phlebology. 2009 Jun;24(3):131–38.
21. Coleridge SP. Chronic venous disease treated by ultrasound guided foam sclerotherapy. Eur J Vasc Endovasc Surg. 2006;32(5):577–83.
22. Morrison N, Neuhardt DL, Hansen Ê. Iracking foam to the heart and brain following ultrasound-guided sclerotherapy of lower extremity veins. Aust NZJPhlebol. 2007;10:6–10.
23. Ceulen RPM. Sommer A, Vernooy K. Microembolism during foam sclerotherapy of varicose veins. N Engl J Med. 2008;358:1525–26.
24. Regan JD, Gibson KD, Ferris B. Safety of proprietary sclerosant microfoam for saphenous incompetence in patients with R-to-L shunt: interim report. J Vasc Interv Radiol. 2008;19(Suppl. 2):S35.
25. Neuhardt DL. Morrison N, Rogers C, Salles-Cunha S. Emboli detection in the middle cerebral artery concurrent with treatment of lower extremity superficial venous insufficiency with foam sclerotherapy (CO2/O2). Phlebology. 2009;24:88–89.
26. Neuhardt DL. Salles-Cunha SX, Morrison N. Emboli detection in the middle cerebral artery during and following foam sclerotherapy (room air) of lower extremity veins. Phlebology. 2008;23(Suppl. 1):8.
27. Forlee MV, Grouden M, Moore DJ, Shanik G. Stroke after varicose vein foam injection sclerotherapy. J Vasc Surg. 2006 Jan;43(1):162–64.
28. Hill D. Hamilton R, Fung T. Assessment of techniques to reduce sclerosant foam migration during ultrasound-guided sclerotherapy of the great saphenous vein. J Vasc Surg. 2008 Oct;48(4):934–39.
29. Hahn M. Schulz T, Junger M. Outcome five years after transcatheter foam sclerotherapy of the greather saphenous vein. Phlebologie Germany. 2008;37:237–40.
30. Jia X, Mowatt G, Burr JM, Cassar K, Cook J, Fraser C. Systematic review of foam sclerotherapy for varicose veins. Br J Surg. 2007 Aug;94(8):925–36. Review.
31. Cavezzi A, Frullini A, Ricci S, Tessari L. Treatment of varicose veins by foam sclerotherapy: two clinical series. Phlebology. 2002;17(1):13–18.
32. Cavezzi A, Frullini A. The role of sclerosing foam in ultrasound guided sclerotherapy of the saphenous veins and of recurrent varicose veins. Austral NZ J Phlebol. 1999;3(2):49–50.
33. Kanter AP, Thibault P. Thibault Saphenofemoral incompetence treated by ultrasound-guided sclerotherapy. Dermatol Surg. 1996;22:648–52.
34. Parsi K, Lim AK. Extended long line echosclerotherapy (ELLE). Australian & Austral NZ J Phlebol. 2000;4(1);6–10.
35. Figueiredo M. Results of Surgical Treatment Compared with Ultrasound-Guided Foam Sclerotherapy in Patients with Varicose Veins: A Prospective Randomised Study. Eur J Vasc Endovasc Surg. 2009;38(Issue 6):758–63.
36. Barret JM, Allen B, Ockelford A, Goldman M. Microfoam Ultrasound-Guided Sclerotherapy Treatment for Varicose Veins in a Subgroup with Diameters at the Junction of 10mm or Greater Compared with a Subgroup of Less Than 10mm. Dermatol Surg. 2004;30:1386–90.
37. Belcaro G, Cesarone MR, Di Renzo A, Brandolini R, Coen L, Acerbi G, Marelli C, Errichi BM, Cazaubon M, Griffin M. Foam-sclerotherapy, surgery, sclerotherapy, and combined treatment for varicose veins: a 10-year, prospective, randomized, controlled, trial (VEDICO trial). Angiology. 2003 May-Jun;54(3):307–15.
38. Smith PC. Chronic venous disease treated by ultrasound guided foam sclerotherapy. Eur J Vasc Endovasc Surg. 2006.;32:577–83.
39. Agus GB, Mancini S, Magi G. The first 1000 cases of Italian Endovenous-laser Working Group (IEWG). Rationale, and long-term outcomes for the 1999-2003 period. Int Angiol. 2006;25:209–15.
40.Gibson KD. Ferris BL, Polissar N. Endovenous laser treatment of the small saphenous vein: efficacy and complications. J Vasc Surg. 2007;45:795–803.
41. Ravi R, Rodriguez-Lopez JA, Trayler EA, Barrett DA, Ramaiah V, Deitrich EB. Endovenous ablation of incompetent saphenous veins: a large single-center experience. J Endovasc Ther. 2006;13:244–48.
42. Almeida JI. Raines JK. Radiofrequency ablation and laser ablation in the treatment of varicose veins. Ann Vasc Surg. 2006;20:547–52.
43. Merchant RF. DePalma RG, Kabnick LS. Endovascular obliteration of saphenous reflux: a multicenter study. J Vasc Surg. 2002;35:1190–96.
44. Merchant RF, Pichot O. Closure Study Group. Long-term outcomes of endovenous radiofrequency obliteration of saphenous reflux as a treatment of superficial venous insufficiency. J Vasc Surg. 2005;42:502–509.
220116, Respublika Belarus, Minsk, pr-t. Dzerzhinskogo, d. 83, UO «Belorusskiy gosudarstvennyiy meditsinskiy universitet», kafedra operativnoy hirurgii i topograficheskry anatomii,
e-mail: dr_shestak@gmail.com,
Shestak Nikita Gennadevich
Baeshko A.A., Doctor of Medical Sciences, Professor, Head of the Operative Surgery and Topographic Anatomy chair of EE “Belarusian State Medical University”
Tikhon S.N., Candidate of Medical Sciences Associate Professor of the Operative Surgery and Topographic Anatomy Chair of EE “Belarusian State Medical University”
Kryzhova E.V., Candidate of Medical Sciences Associate Professor of the Operative Surgery and Topographic Anatomy Chair of EE “Belarusian State Medical University”
Markautsan P.V., Candidate of Medical Sciences Associate Professor of the Operative Surgery and Topographic Anatomy Chair of EE “Belarusian State Medical University”
Vartanyan V.F., Candidate of medical sciences Associate Professor of the Operative Surgery and Topographic Anatomy Chair of EE “Belarusian State Medical University”
Dechko V.M., Candidate of Medical Sciences, Associate Professor of the Operative Surgery and Topographic Anatomy Chair of EE “Belarusian State Medical University”
Kovalevich K.M., Candidate of medical sciences, Associate Professor of the Operative Surgery and Topographic Anatomy Chair of EE “Belarusian State Medical University”
Shestak N.G., A 5-year Student of the Medical Faculty of EE “Belarusian State Medical University”
Article in the .pdf format
